2026 Speakers
19-21 October 2026
RAI Congress Centre, Amsterdam
Peter Aaby, Professor & Founder, Bandim Health Project
Holy Akwar, Science Advisor, Veterinary & AMR, International Centre for Antimicrobial Resistance Solutions (ICARS)
Jeffrey Almond, Former VP Discovery R&D, Sanofi & Visiting Professor, University of Oxford
Christine Stabell Benn, Professor, University of Southern Denmark
Tor Biering-Sorensen, Professor, Faculty of Health and Medical Sciences, University of Copenhagen, Herlev and Gentofte Hospital
Luigi Bonfatti, Executive Advisor, RVMC (Regionalized Vaccine Manufacturing Collaborative)
Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine
Yap Boum II, Deputy Head of the Mpox Response, Africa CDC
Luigi Buonaguro, Lab director, Istituto Nazionale Tumori "Pascale"
David Burkhart, CEO, Inimmune Corp
Robb Butler, Director, Division of Communicable Diseases Environment and Health, World Health Organisation (WHO)
Michael Caldwell, Assoc VP Vaccine Research & Education, Meharry Medical College
Martinus Capelle, Distinguished Scientist II, Janssen
Marco Cavaleri, Head of Public Health Threats, European Medicines Agency
Lucy Chappell, Chief Scientific Adviser, UK Department of Health and Social Care
Johannes Charlier, CEO, Kreavet
Fabrizio Chiodo, Associate Professor, Italian National Research Council
Rory De Vries, Associate Professor, Erasmus M.C.
Andrew Deavin, Senior Director, GSK
Helge Dorfmueller, Professor of Glycoengineering / Founder RHAPSEDA, University of Dundee
Samantha Dowse, Managing Partner/ CMC Consultant, GreyRigge Associates Limited
Viviane Ferraz, Associate Director Patient Safety Scientist, Astra Zeneca
Martin Friede, Head, vaccine research unit, World Health Organization
Pete Gardner, Scientific Director, LifeArc
Mark Geels, Senior Director, IAVI
Martin Peter Grobusch, Professor of Infectious Diseases & Global Health, Amsterdam UMC
Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI
Bassam Hallis, Head of Vaccine Development and Evaluation Centre, UK Health Security Agency (UKHSA)
Jonathan Hare, Translational Science Lead, The Francis Crick Institute
Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
Ana Maria Henao-Restrepo, Lead R&D Blueprint for Epidemics, Health Emergencies Programme (WHE),, World Health Organisation (WHO)
Mark Jit, Chair and Professor, Department of Global and Environmental Health, NEW YORK UNIVERSITY
Jonathan Jones, Manager - Microbial Fermentation, CPI
Erta Kalanxhi, Director of Partnerships, One Health Trust
Judith Kallenberg, Global Health Access Programs & Partnerships Lead, GSK
Zoltán Kis, Senior Lecturer (Associate Professor), Department of Chemical and Biological Engineering, The University of Sheffield
Wayne Koff, Managing Partner, Next Frontier Advisors
Marguerite Koutsoukos, Sr Clinical Science Lead, GSK
Hester Kuipers, Executive Director Europe, IAVI
Darren Leneghan, Consultant, Life Sciences, Venture Valuation
Geert Leroux Roels, Professor Emeritus, Gent University
Stephen Lockhart, Director, Hurst Grange Associates
Shelly Malhotra, Vice President Global Access & External Affairs, IAVI
Gerben Marsman, Head of Alliance Management, Vaccine Formulation Institute
Irina Meln, Head of Innovation, European Vaccine Initiative
Shannon Miller, VP Operations, Inimmune Corporation
Kayvon Modjarrad, Executive Director, Viral Vaccines, Pfizer
Ankur Mutreja, Director of External Affairs and Health Security, South Asia-PATH
Ole Olesen, Executive Director, European Vaccine Initiative
Faith Osier, Co-director, Imperial College London
Arto Palmu, Chief Research and Medical Officer, FVR – Finnish Vaccine Research | FVR – Suomen rokotetutkimus
Wolfgang Philipp, Principal Adviser for Health and Crisis Management, Directorate-General for Health and Food Safety (SANTE), European Comission
Jan Poolman, Executive Advisor & Founder, CreaBacVac B.V.
Maarten Postma, Chair, Faculty of Economics & Business,, University of Groningen
Sankarasubramanian Rajaram, Head of Global Medical Strategy, Seqirus
Raman Rao, Chief Executive Officer, Hilleman Laboratories Singapore Pte Ltd
Rino Rappuoli, Scientific Director, Fondazione Biotecnopolo di Siena
Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE
Reda Sadki, Executive Director, The Geneva Learning Foundation
Jeremy Salt, Chief Executive Officer, The Vaccine Group
Melanie Saville, Chief Scientific Officer, PATH
Anja Schreijer, Medical Director Pandemic and Disaster Preparedness Center, Erasmus MC
Hanneke Schuitemaker, CSO, Valneva Austria GMBH
George Simeon, CEO, Curevo Vaccine
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Miriam Sturkenboom, Professor in RWE & Head, Department of DataScience and Biostatistics, University Medical Center Utrecht & President, VAC4EU
Rajinder Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers Network
Petro Terblanche, Chief Executive Officer, Afrigen Biologics (Pty) Ltd
Nina van Sorge, Head of Netherlands Reference Laboratory for Bacterial Meningitis, AMC
Nico Vandaele, Prof. dr., KU Leuven, Access-To-Medicines Research Centre
Joris Vandeputte, Past President, IABS
Roland Ventura, VFI Advisor, Vaccine Formulation Institute
Charlotte Vernhes, Director Scientific and Medical Affairs, Vaccines Europe
Flavie Vial, Program Officer on Vaccines & Vaccination, WOAH
Elissa R Weitzman, Associate Professor, Director of Research, Boston Children's Hospital, and Harvard Medical School
Richard White, Professor of Infectious Disease Epidemiology, London School of Hygiene and tropical Medicine
Y. Tony Yang, Professor, The George Washington University
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events